ImmunityBio (IBRX) Property, Plant & Equipment (Net) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29% |
| Dec 31, 2025 | -11.83% |
| Sep 30, 2025 | -2.56% |
| Jun 30, 2025 | -1.68% |
| Mar 31, 2025 | -1.33% |
| Dec 31, 2024 | -1.57% |
| Sep 30, 2024 | -1.88% |
| Jun 30, 2024 | -1.09% |
| Mar 31, 2024 | -1.76% |
| Dec 31, 2023 | -3.89% |
| Sep 30, 2023 | 0.34% |
| Jun 30, 2023 | -1.74% |
| Mar 31, 2023 | 7.31% |
| Dec 31, 2022 | 10.13% |
| Sep 30, 2022 | 9.21% |
| Jun 30, 2022 | 13.52% |
| Mar 31, 2022 | 26.98% |
| Dec 31, 2021 | 18.58% |
| Sep 30, 2021 | -21.51% |
| Jun 30, 2021 | 10.07% |
| Mar 31, 2021 | 11.49% |
| Dec 31, 2020 | 29.85% |
| Sep 30, 2020 | -4.69% |
| Jun 30, 2020 | 0.13% |
| Mar 31, 2020 | -3.24% |
| Dec 31, 2019 | -2.66% |
| Sep 30, 2019 | -4.50% |
| Jun 30, 2019 | -4.17% |
| Mar 31, 2019 | -11.66% |
| Dec 31, 2018 | -0.50% |
| Sep 30, 2018 | -1.20% |
| Jun 30, 2018 | 1.80% |
| Mar 31, 2018 | 0.13% |
| Dec 31, 2017 | 3.03% |
| Sep 30, 2017 | 23.67% |
| Jun 30, 2017 | 166.95% |
| Mar 31, 2017 | 19.32% |
| Dec 31, 2016 | 14.76% |
| Sep 30, 2016 | 73.29% |
| Jun 30, 2016 | 32.85% |
| Mar 31, 2016 | 29.57% |
| Dec 31, 2015 | 290.59% |
| Sep 30, 2015 | -48.39% |